(MedPage Today) — The FDA approved extended-release diazoxide choline (Vykat XR) to treat the intense persistent sensation of hunger in patients 4 years of age and older with Prader-Willi syndrome, maker Soleno Therapeutics announced.
“The FDA…
Source link : https://www.medpagetoday.com/endocrinology/growthdisorders/114856
Author :
Publish date : 2025-03-27 18:35:00
Copyright for syndicated content belongs to the linked Source.
